Spironolactone
Product Images NDC 67296-1692

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 67296-1692). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Epm 30 Count (67296 1692 3)

Label for Spironolactone 25 mg tablets, packaged as 30 tablets. The label shows the NDC number 67296-1692-3, and is marked Rx Only. Manufacturer is Cadila Healthcare LTD, Baddi India, with distribution by RedPharm Drug, Inc., Eden Prairie, MN. The label includes lot number B04647X1 and expiration date 11/20, with storage instructions at controlled room temperature (20-25°C, 68-77°F).*

FDA Label Image

Image (B9a028ee 5720 4b9e A625 F7130aafd084 01)

Chemical structure of spironolactone, showing its molecular framework including steroidal rings and functional groups, as depicted in the image provided by RedPharm Drug, Inc.*

FDA Label Image

Image (B9a028ee 5720 4b9e A625 F7130aafd084 02)

A survival probability Kaplan-Meier curve comparing Spironolactone (n=822) and placebo (n=841) over 48 months. The y-axis shows probability from 0.0 to 1.0, and the x-axis shows time in months from 0 to 48. The curve for Spironolactone is dotted and remains higher than the solid placebo line throughout, with a log-rank p-value of less than 0.001.*

FDA Label Image

Image (B9a028ee 5720 4b9e A625 F7130aafd084 03)

A forest plot showing hazard ratios (HR) with 95% confidence intervals (CI) for various subgroups in a study, including age, sex, race, left ventricular ejection fraction (LVEF), heart failure type, NYHA classification, diabetes status, serum creatinine, creatinine clearance, potassium levels, and use of digoxin, ACE inhibitors, and beta blockers. The x-axis ranges from 0.2 to 1.4, indicating the comparative effect between spironolactone and placebo.*

FDA Label Image

Image4 (B9a028ee 5720 4b9e A625 F7130aafd084 04)

Label for Spironolactone Tablets USP, 25 mg, showing a round white tablet imprinted with '660'. The label indicates a package of 100 tablets, Rx only, manufactured by Cadila Healthcare Ltd., India, and distributed by Zydus Pharmaceuticals (USA) Inc. The label includes storage and safety instructions and a barcode.*

FDA Label Image

Image5 (B9a028ee 5720 4b9e A625 F7130aafd084 05)

Label for Spironolactone Tablets, USP 50 mg, showing an oval tablet imprinted with '661'. The label indicates 100 tablets, Rx only, and includes storage and usage instructions. Manufactured by Cadila Healthcare Ltd., India, and distributed by Zydus Pharmaceuticals (USA) Inc., Pennington, NJ. The NDC shown is 68382-661-01.*

FDA Label Image

Image6 (B9a028ee 5720 4b9e A625 F7130aafd084 06)

The label for Spironolactone Tablets USP 100 mg shows images of round white tablets imprinted with '652' and a scored line. The package contains 100 tablets and is marked Rx only. It includes storage instructions, warnings to protect from light, and manufacturer details: Cadila Healthcare Ltd. and distributor Zydus Pharmaceuticals (USA) Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.